The effect of fibrinogen degradation products upon the  -and  -receptors of the adrenergic system in the rat uterus.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005340:Fibrinogen / Q000494:pharmacology*; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D011433:Propranolol / Q000494:pharmacology; D011492:Protein Hydrolysates / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D011955:Receptors, Drug; D013564:Sympathetic Nervous System / Q000187:drug effects*; D014599:Uterus / Q000187:drug effects*
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D011492:Protein Hydrolysates; D011955:Receptors, Drug; D005340:Fibrinogen; D011433:Propranolol; D004837:Epinephrine